Lebrikizumab Treatment in Adults with AsthmaJonathan Corren, John G. Matthews, Robert F. Lemanske et al.|New England Journal of Medicine|2011Cited by 1.5k
An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary DiseaseMark D. Eisner, John R. Balmes, N. Anthonisen et al.|American Journal of Respiratory and Critical Care Medicine|2010Cited by 986
Pulmonary Dead-Space Fraction as a Risk Factor for Death in the Acute Respiratory Distress SyndromeThomas J. Nuckton, Michael A. Matthay, James A Alonso et al.|New England Journal of Medicine|2002Cited by 898
Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*Polly E. Parsons, Arthur P. Wheeler, Mark D. Eisner et al.|Critical Care Medicine|2005Cited by 729
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard TherapyNicola A. Hanania, William W. Busse, Oral Alpan et al.|Annals of Internal Medicine|2011Cited by 550